Forging Ahead on Arabidopsis

With completion of the genome sequence of the tiny mustard plant Arabidopsis imminent, researchers began anticipating the logical next step. Meeting in the fall of 1998 and again in January 2000 under the aegis of the National Science Foundation, they drew up a plan called the 2010 Project, which, if successful, would catalog the functions of all of 'the weed's' 25,000 or so genes. Their goal was ambitious: "to understand every molecular interaction in every cell throughout a plant life cycle."1

Written byBarry Palevitz
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

With The Scientists' report in hand, NSF was ready when molecular biologists completed the Arabidopsis genome in December 2000.2 The foundation made the 2010 Project a reality by soliciting proposals aimed at the plant's functional genomics. Says NSF director Rita Colwell, the agency's effort "is essential to this growing area of biotechnology research and its many applications." On Oct. 1, NSF announced Project 2010's first 28 awards totaling nearly $44 million.

Selected from 106 competitive submissions, the awardees hale from 43 institutions and 20 states. According to Vicki Chandler, president of the American Society of Plant Biologists, "A better understanding [via the 2010 Project] of how plant genes function will have profound benefits for people throughout the world and for our environment. It's a new world we're entering."

The cytochrome P450 gene family is a good example. Mary Schuler of the University of Illinois in Urbana-Champaign wants to characterize Arabidopsis' ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies